Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/01/22 → 31/12/26 |
Funding
- MRFF Medical Research Future Fund
MRFF RCRDUN - Addressing the poor outcomes of young women with hormone receptor-positive, HER2-negative (HR+HER2-) early breast cancer
- Redfern, Andrew (Investigator 01)
- Loi, Sherene (Investigator 02)
- Francis, Prudence (Investigator 03)
- Fox, Stephen (Investigator 04)
- Wilcken, Nicholas (Investigator 05)